tiprankstipranks
Trending News
More News >
Towa Pharmaceutical Co Ltd (JP:4553)
:4553
Japanese Market

Towa Pharmaceutical Co (4553) Financial Statements

Compare
0 Followers

Towa Pharmaceutical Co Financial Overview

Towa Pharmaceutical Co's market cap is currently ¥178.16B. The company's EPS TTM is ¥115.8; its P/E ratio is 8.63; and it has a dividend yield of 2.14%. Towa Pharmaceutical Co is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 259.59B¥ 227.93B¥ 208.86B¥ 165.62B¥ 154.90B
Gross Profit¥ 94.73B¥ 81.38B¥ 72.71B¥ 70.19B¥ 65.45B
Operating Income¥ 23.24B¥ 17.65B¥ 5.51B¥ 19.20B¥ 19.92B
EBITDA¥ 48.05B¥ 35.54B¥ 25.14B¥ 29.49B¥ 29.34B
Net Income¥ 18.99B¥ 16.17B¥ 2.20B¥ 15.91B¥ 13.96B
Balance Sheet
Cash & Short-Term Investments¥ 45.47B¥ 29.65B¥ 24.26B¥ 32.83B¥ 22.91B
Total Assets¥ 470.82B¥ 430.65B¥ 371.35B¥ 329.94B¥ 245.67B
Total Debt¥ 232.37B¥ 202.36B¥ 173.06B¥ 144.13B¥ 84.77B
Net Debt¥ 186.90B¥ 172.71B¥ 148.81B¥ 111.30B¥ 61.85B
Total Liabilities¥ 299.19B¥ 274.76B¥ 234.45B¥ 197.77B¥ 129.07B
Stockholders' Equity¥ 171.63B¥ 155.89B¥ 136.89B¥ 132.17B¥ 116.60B
Cash Flow
Free Cash Flow¥ -5.33B¥ -31.11B¥ -27.93B¥ 8.55B¥ 2.13B
Operating Cash Flow¥ 23.40B¥ 8.21B¥ 2.54B¥ 22.13B¥ 12.01B
Investing Cash Flow¥ -31.29B¥ -40.39B¥ -30.28B¥ -59.73B¥ -9.10B
Financing Cash Flow¥ 21.57B¥ 35.41B¥ 17.48B¥ 46.54B¥ 184.00M
Currency in JPY

Towa Pharmaceutical Co Earnings and Revenue History

Towa Pharmaceutical Co Debt to Assets

Towa Pharmaceutical Co Cash Flow

Towa Pharmaceutical Co Forecast EPS vs Actual EPS